MgScaf-PBDNCT07906730
Magnesium Alloy Scaffold With Controlled Degradation for Periarticular Bone Defects
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Bone Union Rate
Timeframe: 48 weeks after surgery
Secondary (9)
Barthel Index Score for Activities of Daily Living
Patient-Rated Wrist Evaluation (PRWE) Score
Hospital for Special Surgery (HSS) Knee Score
American Shoulder and Elbow Surgeons (ASES) Score
Constant-Murley Shoulder Score
Show 4 moreShow less
Incision Healing Grade
Number of Participants Meeting All Four Device Performance Criteria
Distribution of Participants by CT-Assessed Magnesium Alloy Scaffold Degradation Grade at Week 24
Distribution of Participants by CT-Assessed Magnesium Alloy Scaffold Degradation Grade at Week 48
Arms and interventions
Magnesium Alloy Scaffold GroupExperimental
Participants will undergo open reduction and internal fixation. A customized biodegradable magnesium alloy scaffold with controlled degradation will be implanted into the periarticular bone defect to provide structural support, followed by plate-and-screw fixation.
Calcium Sulfate GroupActive comparator
Participants will undergo conventional open reduction and internal fixation. The periarticular bone defect will be filled with calcium sulfate bone graft substitute.
Devices: Magnesium Alloy Scaffold, Calcium Sulfate Bone Graft Substitute
Sites
4 sites in 1 country